2020 MHC Awards and Recognition

2020 MHC Awards and Recognition

Bibliographic Details
Main Authors:	Amy VandenBerg, PharmD, BCPP, Erica A. K. Davis, PharmD, BCPS, BCPP
Format:	Article
Language:	English
Published:	American Association of Psychiatric Pharmacists 2021-05-01
Series:	Mental Health Clinician
Online Access:	https://theijpt.org/doi/pdf/10.9740/mhc.2021.05.173

Similar Items

2022 MHC Awards and Recognition
by: Erica A. K. Davis, PharmD, BCPS, BCPP, et al.
Published: (2023-03-01)

2021 MHC Awards and Recognition
by: Amy VandenBerg, PharmD, BCPP, et al.
Published: (2022-04-01)

An update on recently approved long-acting injectable second-generation antipsychotics: Knowns and unknowns regarding their use
by: Amy M. VandenBerg, PharmD, BCPP
Published: (2022-11-01)

Response to comment on the recently published article “An update on recently approved long-acting injectable second-generation antipsychotics: Knowns and unknowns regarding their use”
by: VandenBerg Amy M. PharmD, BCPP
Published: (2023-06-01)

Retracing our steps to understand ketamine in depression: A focused review of hypothesized mechanisms of action
by: Madison N. Irwin, PharmD, et al.
Published: (2021-05-01)

Vertigoheel induced psychosis: A patient case report
by: Megan O'Connell, PharmD, BCPP, et al.
Published: (2021-01-01)

Loxapine in patient with clozapine-resistant psychosis
by: Jennifer Erley, PharmD, MBA, BCPS, et al.
Published: (2021-07-01)

Impact of a pharmacist-driven tardive dyskinesia screening service
by: Niyati Butala, PharmD, BCPP, et al.
Published: (2021-07-01)

Characterization of inpatient care for patients admitted to a psychiatric hospital with a home opioid prescription
by: Kei Takamura, PharmD, BCPS, BCPP, et al.
Published: (2023-03-01)

Impact of Board Certified Psychiatric Pharmacists on improving urinary tract infection antibiotic appropriateness at an acute psychiatric hospital
by: Hamad Mohammad Adam PharmD, BCPS, et al.
Published: (2023-10-01)

Differences in serum concentration with valproate oral solution versus delayed-release divalproex in an adherent patient
by: Davis Erica A. K. PharmD, BCPS, BCPP
Published: (2023-06-01)

Impact on hospital-wide antipsychotic prescribing practices through physician peer comparison letters
by: Erica A. K. Davis, PharmD, BCPS, BCPP
Published: (2022-01-01)

Best practice model for outpatient psychiatric pharmacy practice, part 1: Development of initial attribute statements
by: Richard J. Silvia, PharmD, BCPP, et al.
Published: (2022-04-01)

Opioid antagonists to prevent olanzapine-induced weight gain: A systematic review
by: S. Andrea Laguado, PharmD, BCPS, BCPP, et al.
Published: (2023-08-01)

Systematic literature review of the impact of psychiatric pharmacists
by: Jessica L. Ho, PharmD, BCPP, BCPS, et al.
Published: (2024-02-01)

Probable haloperidol decanoate-induced fever in an African American with benign ethnic neutropenia: A case report
by: Lara Youniss, BS, BA, et al.
Published: (2021-09-01)

A Veterans Affairs' perspective in response to Best Practice Model Subcommittee attribute statements for outpatient psychiatric pharmacists
by: Jonathan F. Lister, PharmD, BCPP, et al.
Published: (2022-11-01)

Survey of noncontrolled medication misuse patterns
by: Amelia Slane, PharmD, et al.
Published: (2022-06-01)

Effect of cannabis use on PTSD treatment outcomes in veterans
by: Meagan Petersen, PharmD, BCPP, et al.
Published: (2021-07-01)

Assessment of oral overlap with antipsychotic long-acting injectables initiated in an inpatient setting
by: Tran Jennifer T. PharmD, et al.
Published: (2023-06-01)

COVID-19 reinfection in a patient with a serious mental illness within a long-term inpatient psychiatric care hospital
by: Brianna Englett, PharmD, BCPP, et al.
Published: (2021-09-01)

Development and implementation of a physician-pharmacist collaborative practice model for provision and management of buprenorphine/naloxone
by: Lindsay M. Mailloux, PharmD, et al.
Published: (2021-01-01)

The clinical utility of newer antidepressant agents: Understanding the role in management of MDD
by: Kristin Waters, PharmD, BCPS, BCPP
Published: (2022-11-01)

Publication rates and characteristics of PGY2 psychiatric pharmacy resident research projects
by: Dayton L. Antley, PharmD, BCPS, BCPP, et al.
Published: (2023-01-01)

Addition of a clinical pharmacist practitioner to an inpatient addiction triage team and related medication outcomes
by: Kim Ehrhard, PharmD, BCPP, et al.
Published: (2023-08-01)

Positioning psychiatric pharmacists to improve mental health care
by: Julie A. Dopheide, PharmD, BCPP, FASHP, et al.
Published: (2022-04-01)

Intranasal esketamine use in bipolar disorder: A case report
by: Courtney Skriptshak, PharmD, et al.
Published: (2021-07-01)

Severe olanzapine-induced liver function test elevation
by: Ericka Crouse, PharmD, BCPP, BCGP, FASHP, FASCP, et al.
Published: (2023-01-01)

Psychotropic stewardship: Advancing patient care
by: Haight Robert J. PharmD, BCPP, et al.
Published: (2023-04-01)

Impact of marketing to improve patient access to care and clinic utilization for clinical pharmacy specialists
by: Nora Bairagdar, PharmD, BCPS, et al.
Published: (2023-03-01)

Impact of holding home stimulant(s) on agitation in a child and adolescent inpatient psychiatric population
by: Anupha M. Mathew, PharmD, BCPS, et al.
Published: (2023-03-01)

Pharmacist impact on medication reconciliation of behavioral health patients boarding in the emergency department
by: Mary Accomando, PharmD, BCPP, et al.
Published: (2022-06-01)

Closing the gap: Raising medical professionals' transgender awareness and medical proficiency through pharmacist-led education
by: Ardsley P. Congdon III, PharmD, BCPS, BCPP, et al.
Published: (2021-01-01)

Postinjection delirium/sedation syndrome in a transgender man undergoing hormone therapy
by: Joshua Gerving, PharmD, BCPS, BCPP, et al.
Published: (2023-08-01)

Precipitated withdrawal with kratom use following naltrexone administration
by: Jarka Courtney PharmD, BCPS, BCPP, et al.
Published: (2023-06-01)

Comparison of antipsychotic prescribing practices following failure of antipsychotic monotherapy in the acute care setting
by: Kaitlyn Morgan, PharmD, BCPP, et al.
Published: (2023-01-01)

Moving beyond first-line treatment options for OCD
by: Chris Paxos, PharmD, BCGP, BCPS, BCPP
Published: (2022-11-01)

Ethnopsychopharmacology: Clinical and scientific writing pearls
by: Jonathan G. Leung, PharmD, BCPS, BCPP
Published: (2023-12-01)

Impact of traditional versus nontraditional initiation dosing schedule of paliperidone palmitate on 30-day readmission and safety
by: Erika Kim, PharmD, BCPP, et al.
Published: (2023-12-01)

Best practice model for outpatient psychiatric pharmacy practice, part 2: Confirmation of the attribute statements
by: Kelly C. Lee, PharmD, MAS, BCPP, et al.
Published: (2022-04-01)